# FDA 483 - Bio-Technology General (Israel), Ltd. - March 16, 2023

Source: https://www.globalkeysolutions.net/records/483/bio-technology-general-israel-ltd/f1a4f9b5-347c-497b-bfae-618426631fa7

> FDA 483 for Bio-Technology General (Israel), Ltd. on March 16, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Bio-Technology General (Israel), Ltd.
- Inspection Date: 2023-03-16
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Officers

- [Lei Zhang, Ph.D., Lead Biologist](https://www.globalkeysolutions.net/people/lei-zhang-phd-lead-biologist/4bd40e48-32c6-46fc-a4b9-80523adb937f)
- [Qiong Fu, Ph.D., Investigator](https://www.globalkeysolutions.net/people/qiong-fu-phd-investigator/563c5cbc-6c58-49b9-a3b3-7fd0d6d65fe5)
- [Robert J. Ham, S., Consumer Safety Officer](https://www.globalkeysolutions.net/people/robert-j-ham-s-consumer-safety-officer/a0d9978d-f948-49d4-ae4b-b3a580d57066)
- [Madushani Dharmasema, Ph.D., Senior Pharmaceutical](https://www.globalkeysolutions.net/people/madushani-dharmasema-phd-senior-pharmaceutical/e1658b6a-883a-4386-9a9a-415e225c4e2c)

Company: https://www.globalkeysolutions.net/companies/bio-technology-general-israel-ltd/7e4f2eb9-bacb-4307-9003-5a223c16eed8

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd